Results 1 to 10 of about 133,753 (204)
Results of one study (iPrEx study) showed that a once‑daily pill containing tenofovir plus emtricitabine was safe and provided an average of 44% additional protection against HIV infection to men and transgender women who have sex with men, who were also provided with a comprehensive package of prevention services.
Ajai Kumar Singh +5 more
doaj +5 more sources
Modeling HIV Pre-Exposure Prophylaxis
Pre-exposure prophylaxis (PrEP) has emerged as a promising strategy for preventing the transmission of HIV. Although only one formulation is currently approved for PrEP, research into both new compounds and new delivery systems for PrEP regimens offer ...
Thomas Straubinger +2 more
doaj +3 more sources
Evolving landscape of economic evaluations of HIV pre‐exposure prophylaxis and pre‐exposure prophylaxis implementation strategies: a systematic review [PDF]
Introduction Economic evaluations of HIV pre‐exposure prophylaxis (PrEP) and associated implementation strategies guide evidence‐based policies, programmes and resource allocation.
Min Xi +8 more
doaj +2 more sources
Pre-exposure Prophylaxis: The Delivery Challenge [PDF]
HIV pre-exposure prophylaxis (PrEP), despite its efficacy, has been slow in uptake throughout the world. This article discusses the operational and service delivery complexity, based on early real-world experience, with some recommendations on how this ...
Willem D. F. Venter
doaj +3 more sources
HIV pre-exposure prophylaxis for women
Women and girls comprise nearly half of HIV-infected individuals globally and 20% of new infections in the United States, indicating an urgent need to optimise HIV prevention options in this population.
Anandi N. Sheth +2 more
doaj +3 more sources
HIV pre-exposure prophylaxis [PDF]
Currently, PrEP refers to prophylactic daily oral use of tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), a formulation that is indicated in Canada for the treatment of HIV infection.
Malika, Sharma, Darrell H S, Tan
openaire +2 more sources
Rectal pre-exposure prophylaxis (PrEP) [PDF]
Rectal pre-exposure prophylaxis (PrEP) will be a critical component of HIV prevention products due to the prevalence of unprotected receptive anal intercourse among men who have sex with men and heterosexual couples. Given the biological considerations of this compartment and the complexity of HIV infection, design of a successful rectal microbicide ...
Lisa C, Rohan, Haitao, Yang, Lin, Wang
openaire +2 more sources
Knowledge of PEP and PrEP among people living with HIV/aids in Brazil
Background Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) are key to preventing sexual transmission of HIV, whose sexual partners are at high risk of acquiring HIV.
Laelson Rochelle Milanês Sousa +4 more
doaj +1 more source
Background: Survivors of intimate partner violence are at elevated risk for HIV acquisition, yet there is limited research on the best strategies to optimize biomedical HIV prevention, such as pre-exposure prophylaxis among this population.
Tiara C Willie +5 more
doaj +1 more source
BackgroundMultilevel interventions are necessary to address the complex social contributors to health that limit pre-exposure prophylaxis use among Black women, including medical distrust, pre-exposure prophylaxis stigma, and ...
Schenita D Randolph +3 more
doaj +1 more source

